Ozempic, Zepbound, Wegovy, and other GLP-1 medications have transformed the way we lose weight. People who take them report life-changi ...
Guy's is one of the first hospitals in the country to roll out weight-loss jabs. But whilst millions across the ...
The governor also said she would work with other states to leverage their combined purchasing power to reduce the cost of the ...
Korea Joongang Daily on MSN17h
Hanmi seeks to gain on Wegovy with its own weight-loss drugHanmi Pharmaceutical Senior Vice President Choi In-young, head of the R&D center, speaks to Korean media outlets at a press conference held in San Francisco, California, on Jan. 15. [LEE JAE-LIM] SAN ...
Drugs like Ozempic, Wegovy and Mounjaro are changing the game for weight loss. GLP-1 medications were originally intended to ...
The weight-loss succession race is heating up. Here's how biopharma execs talked up those efforts at JPM this week.
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Eli Lilly trims Q4 guidance but maintains optimism with promising drugs like Zepbound for sleep apnea and global launches ...
The podcast features Numerator Chief Economist Leo Feler, who talks about the potential impact of GLP-1 drugs like Ozempic ...
Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which ...
A new generation of weight loss drugs has helped some people lose significant amounts of weight and improve their health.
Calling people obese is medically "flawed" - and the definition should be split into two, a report from global experts says.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback